Evidence map›Paper›PMID 36145067›Full record

Trial reportNutrients2022

The Effect of Dietary Carbohydrate and Fat Manipulation on the Metabolome and Markers of Glucose and Insulin Metabolism: A Randomised Parallel Trial.

Deaglan McCullough, Tanja Harrison, Lynne M Boddy, Kevin J Enright, Farzad Amirabdollahian, Michael A Schmidt, Katrina Doenges, Kevin Quinn, Nichole Reisdorph, Mohsen Mazidi and 3 more

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 5 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 5 syntheses or guidelines pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Deaglan McCulloughCarnegie School of Sport, Leeds Beckett University, Leeds LS6 3QS, UK.ORCID 0000-0002-9882-9639
Tanja HarrisonDepartment of Clinical Sciences and Nutrition, University of Chester, Chester CH1 4BJ, UK.
Lynne M BoddyResearch Institute of Sport and Exercise Science, Liverpool John Moores University, Liverpool L3 3AF, UK.ORCID 0000-0002-7477-4389
Kevin J EnrightResearch Institute of Sport and Exercise Science, Liverpool John Moores University, Liverpool L3 3AF, UK.
Farzad AmirabdollahianSchool of Public Health Studies, University of Wolverhampton, Wolverhampton WV1 1LY, UK.ORCID 0000-0003-1937-4128
Michael A SchmidtAdvanced Pattern Analysis and Countermeasures Group, Boulder, CO 80302, USA.
Katrina DoengesSkaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora, CO 80045, USA.
Kevin QuinnSkaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora, CO 80045, USA.
Nichole ReisdorphSkaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora, CO 80045, USA.ORCID 0000-0002-0425-8012
Mohsen MazidiClinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford OX3 7LF, UK.
Katie E LaneResearch Institute of Sport and Exercise Science, Liverpool John Moores University, Liverpool L3 3AF, UK.ORCID 0000-0002-9092-2927
Claire E StewartResearch Institute of Sport and Exercise Science, Liverpool John Moores University, Liverpool L3 3AF, UK.
Ian G DaviesResearch Institute of Sport and Exercise Science, Liverpool John Moores University, Liverpool L3 3AF, UK.ORCID 0000-0003-3722-8466
Liverpool John Moores University · GBUniversity of Colorado Anschutz Medical Campus · USKing's College London · GBUniversity of Chester · GBUniversity of Wolverhampton · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High carbohydrate, lower fat (HCLF) diets are recommended to reduce cardiometabolic disease (CMD) but low carbohydrate high fat (LCHF) diets can be just as effective. The effect of LCHF on novel insulin resistance biomarkers and the metabolome has not been fully explored. The aim of this study was to investigate the impact of an ad libitum 8-week LCHF diet compared with a HCLF diet on CMD markers, the metabolome, and insulin resistance markers. n = 16 adults were randomly assigned to either LCHF (n = 8, <50 g CHO p/day) or HCLF diet (n = 8) for 8 weeks. At weeks 0, 4 and 8, participants provided fasted blood samples, measures of body composition, blood pressure and dietary intake. Samples were analysed for markers of cardiometabolic disease and underwent non-targeted metabolomic profiling. Both a LCHF and HCLF diet significantly (p < 0.01) improved fasting insulin, HOMA IR, rQUICKI and leptin/adiponectin ratio (p < 0.05) levels. Metabolomic profiling detected 3489 metabolites with 78 metabolites being differentially regulated, for example, an upregulation in lipid metabolites following the LCHF diet may indicate an increase in lipid transport and oxidation, improving insulin sensitivity. In conclusion, both diets may reduce type 2 diabetes risk albeit, a LCHF diet may enhance insulin sensitivity by increasing lipid oxidation.

Indexed as

Cardiovascular DiseasesDiabetes Mellitus, Type 2Insulin ResistanceAdiponectinAdultBiomarkersDietary CarbohydratesDietary FatsDiet, Carbohydrate-RestrictedGlucoseHumansInsulinLeptinLipidsMetabolomeAdiponectinBiomarkersDietary CarbohydratesDietary FatsGlucoseInsulinLeptinLipidscarbohydratecardiometabolic riskfathigh-fat dietinsulin resistancelow carbohydratemetabolomics

Identifiers

PMID36145067
PMCPMC9505524
OpenAlexW4295007629

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.